CCDC50
protein-codingcoiled-coil domain containing 50
Gene summary
This gene encodes a soluble, cytoplasmic, tyrosine-phosphorylated protein with multiple ubiquitin-interacting domains. Mutations in this gene cause nonsyndromic, postlingual, progressive sensorineural DFNA44 hearing loss. In mouse, the protein is expressed in the inner ear during development and postnatal maturation and associates with microtubule-based structures. This protein may also function as a negative regulator of NF-kB signaling and as an effector of epidermal growth factor (EGF)-mediated cell signaling. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Oct 2008]
- C3orf6
- DFNA44
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~69.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0019497
Submitter: ClinGen
*CCDC50* was first reported in relation to autosomal dominant nonsyndromic hearing loss in 2007 (Modamio-Hoybjor et al., PMID:17503326). Four variants (missense, frameshift) that have been reported in 4 probands in 4 publications (PMIDs: 17503326, 34416374, 33229591, 37165931) are included in this curation. Variants in this gene segregated with disease in 14 additional family members (PMID:17503326). The mechanism of pathogenicity is unknown. This gene-disease association is also supported by an expression study (PMID:17503326). A knockdown mouse model showed no difference in auditory brainstem response thresholds between mutants and controls, so it was not scored (PMID: 37165931). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship. This gene-disease pair was originally evaluated by the ClinGen Hearing Loss GCEP on 12/15/2017 as per SOP v6. It was reevaluated on 6/25/2024 using SOP v10. As a result of this reevaluation, this record underwent an update in scoring to be consistent with SOP v10. New case level and functional evidence has been reviewed or added, but the classification did not change (PMIDs: 34416374, 33229591, 37165931).
Inheritance Pattern: AD
Disease ID:MONDO:0019587
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0011832
Submitter: Ambry Genetics
Inheritance Pattern: Unknown
Disease ID:MONDO:0011832
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
Comments: Hearing loss has been reported to occur in the first decade (6-10 years)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to CCDC50 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_178335.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 32 | 33 | |||
| missense | 143 | 24 | 3 | 170 | ||
| nonsense | 1 | 4 | 5 | |||
| start loss | 0 | |||||
| frameshift | 1 | 4 | 5 | |||
| splice donor/acceptor (+/-2bp) | 2 | 2 | ||||
| Total | 1 | 1 | 154 | 56 | 3 | 215 |
Highest pathogenic variant AF is 6.841995e-7
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_848018.1 | 12 | MANE Select | |
| Ensembl | ENSP00000376249.4 | 12 | MANE Select | |
| RefSeq | NP_777568.1 | 11 | Standard | |
| Ensembl | ENSP00000376250.4 | 11 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- EGFR1
Biological Process
- sensory perception of sound
Molecular Function
- protein binding
- ubiquitin protein ligase binding
Cellular Component
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000392456
- Coding exons
- 12
- Length
- 69594
- Individuals with no LoFs
- 125727
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 20
- Defined
- 125747
- p
- 0.0000795
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0720 | 258 | 261 | 0.987 | 0.0000142 | 3164 |
| Missense (PolyPhen) | 73 | 87.352 | 0.8357 | 1067 | ||
| Synonymous | -0.174 | 95 | 92.9 | 1.02 | 0.00000493 | 847 |
| Loss of Function | 2.70 | 16 | 32.7 | 0.490 | 0.00000192 | 359 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000058 | 0.000058 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.000054 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.00011 | 0.00011 | rare |
| South Asian | 0.000065 | 0.000065 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in EGFR signaling. {ECO:0000269|PubMed:15314609}.;
- Disease
- DISEASE: Deafness, autosomal dominant, 44 (DFNA44) [MIM:607453]: A form of non-syndromic deafness characterized by initially moderate hearing loss that affects mainly low to mid frequencies. Later, it progresses to involve all the frequencies and leads to a profound hearing loss by the 6th decade. {ECO:0000269|PubMed:17503326}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.0930
Intolerance Scores
- LoFtool
- 0.937
- RVIS EVS
- 1.26
- RVIS percentile EVS
- 93.58
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.433
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |